Serina Therapeutics (SER) Receivables - Other (2018 - 2024)
Serina Therapeutics' Receivables - Other history spans 5 years, with the latest figure at $14000.0 for Q3 2024.
- For Q3 2024, Receivables - Other changed N/A year-over-year to $14000.0; the TTM value through Sep 2024 reached $14000.0, changed N/A, while the annual FY2021 figure was $70000.0, 1.41% down from the prior year.
- Receivables - Other for Q3 2024 was $14000.0 at Serina Therapeutics, down from $51000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $141000.0 in Q2 2020 and bottomed at $14000.0 in Q3 2024.
- The 3-year median for Receivables - Other is $71000.0 (2020), against an average of $69444.4.
- The largest annual shift saw Receivables - Other skyrocketed 150.0% in 2020 before it plummeted 31.91% in 2021.
- A 3-year view of Receivables - Other shows it stood at $71000.0 in 2020, then fell by 1.41% to $70000.0 in 2021, then crashed by 80.0% to $14000.0 in 2024.
- Per Business Quant, the three most recent readings for SER's Receivables - Other are $14000.0 (Q3 2024), $51000.0 (Q2 2024), and $70000.0 (Q4 2021).